These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35923805)

  • 1. An enhanced ceramide-based approach for primary prevention of atherosclerotic events.
    Vasile VC; Jaffe AS
    Eur Heart J Open; 2021 Nov; 1(3):oeab016. PubMed ID: 35923805
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic phenotyping of atherosclerotic plaques reveals latent associations between free cholesterol and ceramide metabolism in atherogenesis.
    Vorkas PA; Shalhoub J; Isaac G; Want EJ; Nicholson JK; Holmes E; Davies AH
    J Proteome Res; 2015 Mar; 14(3):1389-99. PubMed ID: 25565173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification.
    Hilvo M; Vasile VC; Donato LJ; Hurme R; Laaksonen R
    Front Endocrinol (Lausanne); 2020; 11():570628. PubMed ID: 33133018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide activation of RhoA/Rho kinase impairs actin polymerization during aggregated LDL catabolism.
    Singh RK; Haka AS; Brumfield A; Grosheva I; Bhardwaj P; Chin HF; Xiong Y; Hla T; Maxfield FR
    J Lipid Res; 2017 Oct; 58(10):1977-1987. PubMed ID: 28814641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.
    Schissel SL; Tweedie-Hardman J; Rapp JH; Graham G; Williams KJ; Tabas I
    J Clin Invest; 1996 Sep; 98(6):1455-64. PubMed ID: 8823312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study.
    Ambrosy AP; Yang J; Sung SH; Allen AR; Fitzpatrick JK; Rana JS; Wagner J; Philip S; Abrahamson D; Granowitz C; Go AS
    J Am Heart Assoc; 2021 Oct; 10(20):e020377. PubMed ID: 34622663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
    Hilvo M; Meikle PJ; Pedersen ER; Tell GS; Dhar I; Brenner H; Schöttker B; Lääperi M; Kauhanen D; Koistinen KM; Jylhä A; Huynh K; Mellett NA; Tonkin AM; Sullivan DR; Simes J; Nestel P; Koenig W; Rothenbacher D; Nygård O; Laaksonen R
    Eur Heart J; 2020 Jan; 41(3):371-380. PubMed ID: 31209498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
    Ogawa H; Nakayama M; Morimoto T; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Saito Y;
    JAMA; 2008 Nov; 300(18):2134-41. PubMed ID: 18997198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Ceramides in Cardiovascular Disease Risk Stratification.
    Junqueira DLM; Stach A; Caixeta A; Sallum J; Yasaki E; Tsutsui J; Rizatti E; Rochitte CE; Ching-Jianhong ; Kovalik JP; Krieger JE; Richards AM; Chan MY; Carvalho LP
    Arq Bras Cardiol; 2022 Apr; 118(4):768-777. PubMed ID: 35508055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease.
    Thobani A; Dhindsa DS; DeMoss BD; Raad M; Sandesara PB; Sperling LS; Baer JT
    Am J Cardiol; 2019 Dec; 124(11):1785-1789. PubMed ID: 31590909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of sphingolipids by normal and atherosclerotic aorta of squirrel monkeys.
    Portman OW; Alexander M
    J Lipid Res; 1970 Jan; 11(1):23-30. PubMed ID: 4983716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention.
    Thanassoulis G; Sniderman AD; Pencina MJ
    JAMA Cardiol; 2018 Nov; 3(11):1090-1095. PubMed ID: 30422172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of ceramide in murine macrophages infected with Leishmania donovani alters macrophage signaling events and aids intracellular parasitic survival.
    Ghosh S; Bhattacharyya S; Das S; Raha S; Maulik N; Das DK; Roy S; Majumdar S
    Mol Cell Biochem; 2001 Jul; 223(1-2):47-60. PubMed ID: 11681721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial.
    Okada S; Morimoto T; Ogawa H; Kanauchi M; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sakuma M; Saito Y;
    Diabetes Care; 2011 Jun; 34(6):1277-83. PubMed ID: 21515838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease.
    Marquis-Gravel G; Roe MT; Harrington RA; Muñoz D; Hernandez AF; Jones WS
    Circulation; 2019 Sep; 140(13):1115-1124. PubMed ID: 31545683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
    Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
    Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study.
    Quispe R; Elshazly MB; Zhao D; Toth PP; Puri R; Virani SS; Blumenthal RS; Martin SS; Jones SR; Michos ED
    Eur J Prev Cardiol; 2020 Oct; 27(15):1597-1605. PubMed ID: 31291776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis.
    Stewart CE; Newcomb PV; Savage PB; Dickens M; Tavare J; Holly JM
    Growth Horm IGF Res; 1999 Apr; 9(2):131-42. PubMed ID: 10373346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous ceramide contributes to the transcytosis of oxLDL across endothelial cells and promotes its subendothelial retention in vascular wall.
    Li W; Yang X; Xing S; Bian F; Yao W; Bai X; Zheng T; Wu G; Jin S
    Oxid Med Cell Longev; 2014; 2014():823071. PubMed ID: 24817993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
    Zelniker TA; Wiviott SD; Raz I; Im K; Goodrich EL; Bonaca MP; Mosenzon O; Kato ET; Cahn A; Furtado RHM; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Sabatine MS
    Lancet; 2019 Jan; 393(10166):31-39. PubMed ID: 30424892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.